Gastrointestinal Stromal Tumor (GIST) Clinical Trial
Official title:
A Phase Ib/II Study of MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
The purpose of this study is to evaluate the effects, good and/or bad, of MEK162 and imatinib on the patient and on Gastrointestinal Stromal Tumor (GIST). Funding Source - FDA OOPD, Array/Pfizer
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02574663 -
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
|
Phase 1 | |
| Completed |
NCT01135849 -
B-Receptor Signaling in Cardiomyopathy
|
N/A | |
| Completed |
NCT00464620 -
Trial of Dasatinib in Advanced Sarcomas
|
Phase 2 | |
| Completed |
NCT00623831 -
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
|
Phase 1 | |
| Completed |
NCT01294202 -
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
|
Phase 2 | |
| Completed |
NCT00785785 -
A Study of Nilotinib Versus Imatinib in GIST Patients
|
Phase 3 | |
| Recruiting |
NCT02443948 -
Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)
|
N/A | |
| Recruiting |
NCT01034670 -
Advanced Gastrointestinal Endoscopic Imaging
|
N/A | |
| Completed |
NCT00867113 -
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
|
Phase 2 | |
| Active, not recruiting |
NCT01391611 -
Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)
|
Phase 2 | |
| Terminated |
NCT02452424 -
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03594422 -
A Study of HQP1351 in Patients With GIST or Other Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05453292 -
Endoscopic Ultrasound Radiofrequency Ablation for GISTs
|
N/A | |
| Completed |
NCT00780494 -
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
|
Phase 2 | |
| Recruiting |
NCT04557969 -
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
|
||
| Completed |
NCT03404076 -
Unifying Advanced Treatment With Advanced Imaging
|
||
| Recruiting |
NCT04821895 -
Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients
|
||
| Completed |
NCT01316263 -
A Study of IMC-3G3 in Previously Treated Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors
|
Phase 2 | |
| Terminated |
NCT00767234 -
Permission to Collect Blood Over Time for Research
|
N/A | |
| Recruiting |
NCT01048281 -
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
|